Last reviewed · How we verify

Intra articular injection of HA

Fayoum University · Phase 1 active Small molecule Quality 15/100

Intra articular injection of HA is a Small molecule drug developed by Fayoum University. It is currently in Phase 1 development.

At a glance

Generic nameIntra articular injection of HA
SponsorFayoum University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intra articular injection of HA

What is Intra articular injection of HA?

Intra articular injection of HA is a Small molecule drug developed by Fayoum University.

Who makes Intra articular injection of HA?

Intra articular injection of HA is developed by Fayoum University (see full Fayoum University pipeline at /company/fayoum-university).

What development phase is Intra articular injection of HA in?

Intra articular injection of HA is in Phase 1.

What are the side effects of Intra articular injection of HA?

Common side effects of Intra articular injection of HA include Arthralgia, Headache, Viral upper respiratory tract infection, Injection site pain, Joint swelling, Toothache.

Related